Preventable cases of autism: Relationship between chronic infectious diseases and neurological outcome

Pediatric Health

Volumn 3, Issue 2, 2009, Pages 125-140

  Bransfield, Robert C ^a  

^a Riverview Medical Center   (United States)

Author keywords

Autism; Autism spectrum disorders; Bartonella; Borrelia burgdorferi; Chlamydia pneumonia; Infections; Lyme; Mycoplasma; Tick borne

Indexed keywords

ANTIBIOTIC AGENT; ANTISTREPTOLYSIN;

ADULT; ARTICLE; ASPERGER SYNDROME; AUTISM; BABESIA; BARTONELLA HENSELAE; BORRELIA BURGDORFERI; BRAIN ATROPHY; CASE REPORT; CHRONIC FATIGUE SYNDROME; DEPRESSION; EPSTEIN BARR VIRUS; FAMILY HISTORY; FEMALE; GENERALIZED ANXIETY DISORDER; GRAND MAL SEIZURE; HUMAN; HUMAN HERPESVIRUS 6; INFECTION; INFECTIOUS MONONUCLEOSIS; LYME DISEASE; MALE; MIXED INFECTION; MOOD DISORDER; MULTIPLE SCLEROSIS; MYCOPLASMA FERMENTANS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; POSTTRAUMATIC STRESS DISORDER; PREVENTION STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOCIAL PHOBIA; STREPTOCOCCUS GROUP G; VIRUS INFECTION;

EID: 70349645686     PISSN: 17455111     EISSN: None     Source Type: Journal    
DOI: 10.2217/phe.09.5     Document Type: Article

References (102)

1. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (Text Revision). American Psychiatric Press, VA, USA 299.00-299.80 (2000).
2. Landa R, Holman KC, Garrett-Mayer E: Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders. Arch. Gen. Psych. 64, 853-864 (2007).
3. Irva Hertz-Picciottoa I, Delwichea L: The rise in autism and the role of age at diagnosis. Epidemiology 20, 84-90 (2009).
4. Kippes C, Garrison CB: Are we in the midst of an autism epidemic? A review of prevalence data. Mo. Med. 103(1), 65-68 (2006).
5. Wazana A, Bresnahan M, Kline J: The autism epidemic: fact or artifact? J. Am. Acad. Child Adolesc. Psychiatry 46(6), 721-730 (2007).
6. Ganz ML: The lifetime distribution of the incremental societal costs of autism. Arch. Pediatr. Adolesc. Med. 161(4), 343-349 (2007).
7. Chess S: Autism in children with congenital rubella. J. Autism Child Schizophr. 1(1), 33-47 (1971).
8. Aboudy Y, Fogel A, Barnea B et al.: Subclinical rubella reinfection during pregnancy followed by transmission of virus to the fetus. J. Infect. 34(3), 273-276 (1997).
9. Veenstra-Vanderweele J, Cook E Jr, Lombroso PJ: Genetics of childhood disorders: Autism, part 5: genetics of autism. J. Am. Acad. Child Adolesc. Psych. 42(1), 116-118 (2003).
10. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS: Autistic disorder and viral infections. J Neurovirol. 11(1), 1-10 (2005).
11. Mc Ewen: Mood disordersand allostatic load. Biol. Psych. 54(3), 200-207 (2003).
12. Schapira AH, Olanow CW: Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions. JAMA 291, 358-364 (2004).
13. Rice D, Barone S Jr: Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108 (Suppl. 3), 511-533 (2000).
14. Yolken RH: Oral presentation. Presented at: Microbes and Mental Illness Symposium. PA, USA 2000.
15. Gregg JP, Lit L, Baron CA et al.: Gene expression changes in children with autism. Genomics 91(1), 22-29 (2008).
16. Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier M R: A prospective study of transsulfuration biomarkers in autistic disorders. Neurochemical Research DOI:10.1007/s11064-008-9782-x (2008) (In Press).
17. Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C: Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 12(2), 203-209(2006).
18. Waldman M, Nicholson S, Adilov N, Williams J: Autism prevalence and precipitation rates in California, Oregon, and Washington counties. Arch. Pediatr. Adolesc. Med. 162(11), 1026-1034(2008).
19. Bransfield RC, Wulfman JS, Harvey WT, Usman AI: The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders. Med. Hypotheses 70(5), 967-974(2008).
20. Bransfield RC: Comorbid Lyme, tick-borne diseases and neuropsychiatric disorders. Special Report: Psychiatric Times 24(14), (2007).
21. Hájek T, Libiger J, Janovská D, Hájek P, Alda M, Höschl C: Clinical and demographic characteristics of psychiatric patients seropositive for Borrelia burgdorferi. Eur. Psychiatry 21(2), 118-122 (2006).
22. Sun Y, Vestergaard M, Christensen J, Nahmias AJ, Olsen J: Prenatal exposure to maternal infections and epilepsy in childhood: a population-based cohort study. Pediatrics 121(5), E1100-E1107 (2008).
23. Torrey E.F, Miller J, Rawlings R, Yolken RH: Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr. Res. 28(1), 1-38 (1997).
24. Mednick SA, Machon RA, Huttunen MO, Bonett D: Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry 45(2), 189-192 (1988).
25. Brown AS, Begg MD, Gravenstein S et al.: Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 61(8), 774-780 (2004).
26. Niebuhr DW, Millikan AM, Cowan DN, Yolken R, Li Y, Weber NS: Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am. J. Psychiatry 165(1), 99-106 (2008).
27. Fellerhoff B, Laumbacher B, Mueller N, Gu S, Wank R: Associations between Chlamydophila infections, schizophrenia and risk of HLA-A10. Mol. Psychiatry 12(3), 264-272 (2007).
28. Buka SL, Cannon TD, Torrey EF, Yolken RH; Collaborative Study Group on the Perinatal Origins of Severe Psychiatric Disorders: Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol. Psychiatry 63(8), 809-815 (2008).
29. Gilmore JH, Jarskog LF, Vadlamudi S, Lauder JM: Prenatal infection and risk for schizophrenia: IL-1β, IL-6, and TNFα Inhibit cortical neuron dendrite development. Neuropsychopharmacology 29, 1221-1229 (2004).
30. Wright P, Gill M, Murray RM: Schizophrenia: genetics and the maternal immune response to viral infection. Am. J. Med. Genet. 48(1), 40-46 (1993).
31. Stubbs EG, Crawford ML: Depressed lymphocyte responsiveness in autistic children. J. Autism Child Schizophr. 7(1), 49-55 (1997).
32. De Tiege X, De Laet C, Mazoin N et al.: Postinfectious immune-mediated encephalitis after pediatric herpes simplex encephalitis. Brain Dev. 27(4), 304-307 (2005).
33. DeLong GR, Bean SC, Brown FR 3rd: Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch. Neurol. 38(3), 191-194 (1981).
34. Lancaster K, Dietz DM, Moran TH, Pletnikov MV: Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus. Behav. Brain Res. 176(1), 141-148 (2007).
35. Markowitz PI: Autism in a child with congenital Cytomegalovirus infection. J. Autism Dev. Disord. 13(3) (1983).
36. Stubbs EG, Ash E, Williams CPS: Autism and congenital Cytomegalovirus. J. Autism Dev. Disord. 14(2) (1984).
37. Yamashita Y, Fujimoto C, Nakajima E et al.: Possible association between congenital Cytomegalovirus infection and autistic disorder. J. Autism Dev. Disord. 33, 355-359 (2003).
38. Auvichayapat N, Auvichayapat P, Watanatorn J, Thamaroj J, Jitpimolmard S: Kluver-Bucy syndrome after mycoplasmal bronchitis. Epilepsy Behav. 8(1), 320-322 (2005).
39. Nicolson GL, Berns P, Gan R et al.: Chronic mycoplasmal infections in Gulf War veterans' children and autism patients. Med. Veritas 2, 383-387 (2005).
40. Nicolson GL: Chronic bacterial and viral infections in neurodegenerative and neurobehavioral diseases. Lab. Med. 39(5), 291-299 (2008).
41. Nicolson GL, Gan R, Nicolson NL et al.: Evidence for Mycoplasma, Chlamydia pneunomiae and HHV-6 co-infections in the blood of patients with autism spectrum disorders. J. Neurosci. Res. 85, 1143-1148 (2007).
42. Guedalia JS, Zlotogorski Z, Goren A, Steinberg A: A reversible case of Kluver-Bucy syndrome in association with shigellosis. J. Child. Neurol. 8(4), 313-315 (1993).
43. Patel R, Jha S, Yadav RK: Pleomorphism of the clinical manifestations of neurocysticercosis. Trans. R Soc. Trop. Med. Hyg. 100(2), 134-141 (2006).
44. Mankoski RE, Collins M, Ndosi NK, Mgalla EH, Sarwatt VV, Folstein SE: Etiologies of autism in a case-series from Tanzania. J. Autism Dev. Disord. 36(8), 1039-1051 (2006).
45. Thong YH: Reptilian behavioural patterns in childhood autism. Med. Hypotheses 13(4), 399-405 (1984).
46. Boorom KF: Is this recently characterized gastrointestinal pathogen responsible for rising rates of inflammatory bowel disease (IBD) and IBD associated autism in Europe and the United States in the 1990s? Med. Hypotheses 69(3), 652-659 (2007).
47. Manoj K, Puthia MK, Lu J, Tan KS: Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-κB-dependent manner. Eukaryotic Cell 7(2)435-443 (2008).
48. Singh VK and Jensen RL: Elevated levels of measles antibodies in children with autism. Pediatric Neurol. 28, 292-294 (2003).
49. Singh VK, Lin SX, Yang VC: Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin. Immunol. Immunopathol. 89, 105-108 (1998).
50. Mankoski RE, Collins M, Ndosi NK, Mgalla EH, Sarwatt VV, Folstein SE: Etiologies of autism in a case-series from Tanzania. J. Autism Dev. Disord. 36(8), 1039-1051 (2006).
51. Halsey NA, Hyman SL: Measles-mumps-rubella vaccine and ASD: report from the new challenges in childhood immunizations conf. Pediatrics 107(5), E84 (2001).
52. Mattman LH: Cell wall deficient forms: Stealth pathogens. CRC Press (2000).
53. Baron-Cohen S, Ring HA, Bullmore ET, Wheelwright S, Ashwin C, Williams SC: The amygdala theory of autism. Neurosci. Biobehav. Rev. 24(3), 355-364. (2000).
54. Hetzler BE, Griffin JL: Infantile autism and the temporal lobe of the brain. J. Autism Dev. Disord. 11(3), 317-330 (1981).
55. Hagberg H, Mallard C: Effect of inflammation on central nervous system development and vulnerability: review. Curr. Opin. Neurol. 18(2), 117-123 (2005).
56. Meyer U, Yee BK, Feldon J: The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist. 13(3), 241-256 (2007).
57. Smith SE, Li J, Garbett K, Mirnic K, Patterson PH: Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 27(40), 10695-10702 (2007).
58. Shi L, Fatemi SH, Sidwell RW, Patterson PH: Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23(1), 297-302 (2003).
59. Fatemi SH, Reutiman TJ, Folsom TD, Sidwell RW: The role of cerebellar genes in pathology of autism and schizophrenia. Cerebellum 99(1-3), 56-70 (2008).
60. Fatemi SH, Reutiman TJ, Folsom TD et al.: Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr. Res. 99(1-3), 56-70 (2008).
61. Rice D, Barone S: Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108 (Suppl. 3), 511-533 (2000).
62. Martin LA, Ashwood P, Braunschweig D, Cabanlit M, Van de Water J, Amaral DG: Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav. Immun. 22(6), 806-816. (2008).
63. Zimmerman AW, Connors SL, Matteson KJ et al.: Maternal antibrain antibodies in autism. Brain Behav. Immun. 21(3), 351-357 (2007).
64. Hertz-Picciotto I, Hansen R, Croen LA, Pessah IN, Van de Water J: Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 29(2), 226-231. (2008).
65. Singer HS, Morris CM, Gause CD, Gillin PK, Crawford S, Zimmerman AW: Antibodies against fetal brain in sera of mothers with autistic children. Neuroimmunol. 194(1-2), 165-172 (2008).
66. Croen LA, Braunschweig D, Haapanen L et al.: Maternal mid-pregnancy autoantibodies to fetal brain protein: the Early Markers for Autism Study. Biol. Psychiatry 64(7), 583-588. (2008).
67. Fleury B, Bergonier D, Berthelot X, Peterhans E, Frey J, Vilei EM: Characterization of P40, a cytadhesin of Mycoplasma agalactiae. Infect. Immun. 70(10), 5612-5621 (2002).
68. Gorton TS, Geary SJ: Antibody-mediated selection of a Mycoplasma gallisepticum phenotype expressing variable proteins. FEMS Microbiol. Lett. 155(1), 31-38 (1997).
69. Hasebe A, Mu HH, Washburn LR et al.: Inflammatory lipoproteins purified from a toxigenic and arthritogenic strain of Mycoplasma arthritidis are dependent on Toll-like receptor 2 and CD14. Infect. Immun. 2007 75(4), 1820-1826 (2007).
70. Kanamoto Y, Iijima Y, Miyashita N, Matsumoto A, Sakano T: Antigenic characterization of Chlamydia pneumoniae isolated in Hiroshima, Japan. Microbiol. Immunol. 37(6), 495-498 (1993).
71. Choi IH, Shim JH, Kim SW, Kim SN, Pyo SN, Rhee DK: Limited stress response in Streptococcus pneumoniae. Microbiol. Immunol. 43(8), 807-812 (1999).
72. Degiorgis MP, Abdo EM, Nicolet J, Frey J, Mayer D, Giacometti M: Immune responses to Mycoplasma conjunctivae in alpine ibex, alpine chamois, and domestic sheep in Switzerland. J. Wildl. Dis. 36(2), 265-271 (2000).
73. Haimerl M, Tenter AM, Simon K, Rommel M, Hilger J, Autenrieth IB: Seroprevalence of Bartonella henselae in cats in Germany. J. Med. Microbiol. 48(9), 849-856 (1999).
74. Cinco M, Murgia R, Ruscio M, Andriolo B: IgM and IgG significant reactivity to Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii among Italian patients affected by Lyme arthritis or neuroborreliosis. Immunol. Med. Microbiol. 14(2-3), 159-166 (1996).
75. Luft BJ, Gorevic PD, Jiang W, Munoz P, Dattwyler RJ: Immunologic and structural characterization of the dominant 66- to 73-kDa antigens of Borrelia burgdorferi. J. Immunol. 146(8), 2776-2782 (1991).
76. Schapira AH, Olanow CW: Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions. JAMA 291, 358-364 (2004).
77. Wichers MC, Maes M: The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-a-induced depression. J. Psychiatry Neurosci. 29(1), 11-17 (2004).
78. Stone TW, Mackay GM, Forrest CM, Clark CJ, Darlington LG: Tryptophan metabolites and brain disorders. Clin. Chem. Lab Med. 41(7), 852-859 (2003).
79. Halperin JJ, Heyes MP: Neuroactive kynurenines in Lyme borreliosis. Neurology 42(1), 43-50 (1992).
80. Gregg JP, Lit L, Baron CA et al.: Gene expression changes in children with autism. Genomics 91(1), 22-29 (2008).
81. Dorward DW, Fischer ER, Brooks DM: Invasion and cytopathic killing of human lymphocytes by spirochetes causing Lyme disease. Clin. Infect. Dis. 25 (Suppl. 1), S2-S8 (1997).
82. Stricker RB, Winger EE: Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol. Lett. 76(1), 43-48 (2001).
83. Chauhan A, Chauhan V: Oxidative stress in autism. Pathophysiol. 13(3), 171-181 (2006).
84. Chauhan A, Chauhan V, Brown WT, Cohen I: Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteins. Life Sci. 75(21), 2539-2549 (2004).
85. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA: Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80(6), 1611-1617 (2004).
86. Pancewicz SA, Skrzydlewska E, Hermanowska-Szpakowicz T, Stankiewicz A, Kondrusik M: Evaluation of oxidoreductive potential of patients with neuroborreliosis. Przegl. Epidemiol. 56(3), 425-433 (2002).
87. Pancewicz SA, Skrzydlewska E, Hermanowska-Szpakowicz T, Zajkowska JM, Kondrusik M: Role of reactive oxygen species in patients with erythema migrans, an early manifestation of Lyme borreliosis. Med. Sci. Monit. 7(6), 1230-1235 (2001).
88. Schlesinger PA, Duray PH, Burke BA, Steere AC, Stillman MT: Maternal-fetal transmission of the LYD spirochete, B. burgdorferi. Ann. Intern. Med. 103(1), 67-68 (1985).
89. MacDonald AB: Gestational Lyme borreliosis. Implications for the fetus. Rheum. Dis. Clin. North Am. 15(4), 657-677 (1989).
90. Harvey, WT; Salvato, P: 'Lyme disease': ancient engine of an unrecognized borreliosis pandemic? Med. Hypotheses 60(5), 742-759 (2003).
91. Schmidt BL, Aberer E, Stockenhuber C, Klade H, Breier F, Luger A: Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis. Diagn. Microbiol. Infect. Dis. 21(3), 121-128 (1995).
92. Hercogová J, Tománková M, Frösslová D, Janovská D: Early-stage lyme borreliosis during pregnancy: treatment in 15 women with erythema migrans. Cesk Gynekol. 58(5), 229-232 (1993).
93. Nadal D, Hunziker UA, Bucher HU, Hitzig WH, Duc G: Infants born to mothers with antibodies against Borrelia burgdorferi at delivery. Eur. J. Pediatr. 148(5), 426-427 (1989).
94. Lavoie PE, Lattner BP, Duray PH et al.: Culture positive, seronegative, transplacental Lyme borreliosis infant mortality. Arthritis Rheum. 3, S50 (1987).
95. Hercogova J, Vanousova D: Syphilis and borreliosis during pregnancy. Dermatol. Ther. 21(3), 205-209 (2008).
96. Gardner T: Lyme disease. 66 pregnancies complicates by Lyme borreliosis. In: Infectious Diseases of the Fetus and Newborn Infant. Saunders, PA, USA (2000).
97. Jones CR, Smith H, Gibb E, Johnson L: Gestational Lyme disease case studies of 102 live births. Lyme Times 34-36 (2005).
98. Owen DC: Is Lyme disease always poly microbial? - the jigsaw hypothesis. Med. Hypotheses 67(4), 860-864 (2006).
99. Stricker RB: Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease. Clin. Infect. Dis. 45(2), 149-157 (2007).
100. Stricker RB, Johnson L: Lyme wars: let's tackle the testing. BMJ 35(7628), 1008 (2007).
101. Sandler RH, Finegold SM, Bolte ER et al.: Short-term benefit from oral vancomycin treatment of regressive-onset autism. J. Child. Neurol. 15(7), 429-435 (2000).
102. Maraspin V, Cimperman J, Lotric-Furlan S, Pleterski-Rigler D, Strle F: Erythema migrans in pregnancy. Wien Klin Wochenschr. 111(22-23), 933-940 (1999).